Dorothy Hallberg

1.3k total citations
6 papers, 132 citations indexed

About

Dorothy Hallberg is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Dorothy Hallberg has authored 6 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Dorothy Hallberg's work include Cancer Mechanisms and Therapy (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Melanoma and MAPK Pathways (2 papers). Dorothy Hallberg is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Melanoma and MAPK Pathways (2 papers). Dorothy Hallberg collaborates with scholars based in United States and France. Dorothy Hallberg's co-authors include Victor E. Velculescu, Ronny Drapkin, Gottfried E. Konecny, Dennis J. Slamon, Dylan Conklin, Michaël Noë, Vilmos Adleff, Roger H. Reeves, Hariharan Easwaran and Stephen B. Baylin and has published in prestigious journals such as Science, Cell Reports and Molecular Cancer Therapeutics.

In The Last Decade

Dorothy Hallberg

4 papers receiving 131 citations

Peers

Dorothy Hallberg

MB

RM

ONCOL

CR

PFM

Salma El-Sahhar United Kingdom

Joanna Plisiecka-Hałasa Poland

Ian Croy United Kingdom

Kay Y. Chong China

Chenlu Wang China

Divya Kriplani United Kingdom

Wendy A. van Zelst-Stams Netherlands

Émilie Indersie France

Raúl Navaridas Spain

Lingzi Lei China

Salma El-Sahhar United Kingdom

Dorothy Hallberg

85 ×1.0

MB

39 ×0.8

RM

62 ×1.4

ONCOL

62 ×1.7

CR

8 ×0.3

PFM

Citations per year, relative to Dorothy Hallberg Dorothy Hallberg (= 1×) peers Salma El-Sahhar

Countries citing papers authored by Dorothy Hallberg

Since Specialization

Citations

This map shows the geographic impact of Dorothy Hallberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothy Hallberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothy Hallberg more than expected).

Fields of papers citing papers by Dorothy Hallberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothy Hallberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothy Hallberg. The network helps show where Dorothy Hallberg may publish in the future.

Co-authorship network of co-authors of Dorothy Hallberg

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothy Hallberg. A scholar is included among the top collaborators of Dorothy Hallberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothy Hallberg. Dorothy Hallberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Konecny, Gottfried E., Coriolan Lebreton, Melissa C. Larson, et al.. (2025). Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer. International Journal of Gynecological Cancer. 35(10). 102028–102028.

2.

Smith, Jesse S., Sacha Vignieri, Bianca Lopez, et al.. (2025). In Science Journals. Science. 389(6766). 1202–1204.

3.

Zervantonakis, Ioannis K., Laura M. Selfors, Sangeetha Palakurthi, et al.. (2019). Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness. Molecular Cancer Therapeutics. 18(3). 642–655. 36 indexed citations

4.

Campos, Maira P., Erika von Euw, Victor E. Velculescu, et al.. (2018). BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition. JCO Precision Oncology. 2(2). 1–6. 6 indexed citations

5.

Papp, Eniko, Dorothy Hallberg, Gottfried E. Konecny, et al.. (2018). Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines. Cell Reports. 25(9). 2617–2633. 78 indexed citations

6.

Hallberg, Dorothy, et al.. (2014). Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice. Mechanisms of Development. 135. 68–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact